全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
Antibodies  2013 

Characterization of a Phospho-Specific Antibody to the Fcε Receptor γ Chain, Reveals Differences in the Regulation of Syk and Akt Phosphorylation

DOI: 10.3390/antib2020321

Keywords: phospho-specific antibody, mast cell, FcεRI, immunoreceptor tyrosine-based activation motif (ITAM), Akt, Syk

Full-Text   Cite this paper   Add to My Lib

Abstract:

We previously demonstrated that the Fc receptor γ-chain Y 58(C-terminal tyrosine) is highly susceptible to dephosphorylation; a mechanism that controls the extent of Syk activation and the downstream signaling in mast cells. Here, we explored the importance of the γ-chain Y 47 (N-terminal tyrosine) in mast cell signaling. We generated a highly sensitive and versatile phospho-specific antibody that recognized the phosphorylated Y 47 in various species. Using this antibody, we found that mutation of the FcεRIβ Y 219 to phenylalanine caused a loss in the phosphorylation of the γ-chain Y 47, consistent with the previously described role of Y 219 in Lyn association with FcεRIβ and subsequent FcεRIγ phosphorylation. These conditions also diminished the tyrosine phosphorylation of Syk and LAT1 but, surprisingly, not the phosphorylation of Akt at T 308. Mutation of Y 47 or Y 58 of the γ-chain also caused a marked inhibition of Syk and LAT1 phosphorylation, but only the latter mutant showed a reduction in Akt phosphorylation. These findings show that the full phosphorylation of Syk and LAT1 requires the FcεRIβ Y 219 and both Y 47 and Y 58 of the γ-chain. However, T 308 phosphorylation of Akt is largely independent of FcεRIγ Y 47 phosphorylation and of the Lyn-binding site (Y 219) on the FcεRIβ.

References

[1]  Rivera, J.; Fierro, N.A.; Olivera, A.; Suzuki, R. New insights on mast cell activation via the high affinity receptor for IgE. Adv. Immunol. 2008, 98, 85–120, doi:10.1016/S0065-2776(08)00403-3.
[2]  Alvarez-Errico, D.; Lessmann, E.; Rivera, J. Adapters in the organization of mast cell signaling. Immunol. Rev. 2009, 232, 195–217, doi:10.1111/j.1600-065X.2009.00834.x.
[3]  Rivera, J.; Gilfillan, A.M. Molecular regulation of mast cell activation. J. Allergy Clin. Immunol. 2006, 117, 1214–1225, doi:10.1016/j.jaci.2006.04.015.
[4]  Kihara, H.; Siraganian, R.P. Src homology 2 domains of Syk and Lyn bind to tyrosine-phosphorylated subunits of the high affinity IgE receptor. J. Biol. Chem. 1994, 269, 22427–22432.
[5]  Benhamou, M.; Ryba, N.J.; Kihara, H.; Nishikata, H.; Siraganian, R.P. Protein-tyrosine kinase p72syk in high affinity IgE receptor signaling. Identification as a component of pp72 and association with the receptor γ chain after receptor aggregation. J. Biol. Chem. 1993, 268, 23318–23324.
[6]  On, M.; Billingsley, J.M.; Jouvin, M.H.; Kinet, J.P. Molecular dissection of the FcRβ signaling amplifier. J. Biol. Chem. 2004, 279, 45782–45790.
[7]  Nunomura, S.; Kawakami, Y.; Kawakami, T.; Ra, C. The FcRβ- and γ-ITAMs play crucial but distinct roles in the full activation of mast cells induced by IgEκ and Protein L. J. Immunol. 2012, 188, 4052–4064, doi:10.4049/jimmunol.1102796.
[8]  Xiao, W.; Nishimoto, H.; Hong, H.; Kitaura, J.; Nunomura, S.; Maeda-Yamamoto, M.; Kawakami, Y.; Lowell, C.A.; Ra, C.; Kawakami, T. Positive and negative regulation of mast cell activation by Lyn via the FcεRI. J. Immunol. 2005, 175, 6885–6892.
[9]  Furumoto, Y.; Nunomura, S.; Terada, T.; Rivera, J.; Ra, C. The FcεRIβ immunoreceptor tyrosine-based activation motif exerts inhibitory control on MAPK and IκB kinase phosphorylation and mast cell cytokine production. J. Biol. Chem. 2004, 279, 49177–49187.
[10]  Chen, T.; Repetto, B.; Chizzonite, R.; Pullar, C.; Burghardt, C.; Dharm, E.; Zhao, Z.; Carroll, R.; Nunes, P.; Basu, M.; et al. Interaction of phosphorylated FcεRIγ immunoglobulin receptor tyrosine activation motif-based peptides with dual and single SH2 domains of p72syk. Assessment of binding parameters and real time binding kinetics. J. Biol. Chem. 1996, 271, 25308–25315.
[11]  Kimura, T.; Kihara, H.; Bhattacharyya, S.; Sakamoto, H.; Appella, E.; Siraganian, R.P. Downstream signaling molecules bind to different phosphorylated immunoreceptor tyrosine-based activation motif (ITAM) peptides of the high affinity IgE receptor. J. Biol. Chem. 1996, 271, 27962–27968.
[12]  Yamashita, T.; Suzuki, R.; Backlund, P.S.; Yamashita, Y.; Yergey, A.L.; Rivera, J. Differential dephosphorylation of the FcRγ immunoreceptor tyrosine-based activation motif tyrosines with dissimilar potential for activating Syk. J. Biol. Chem. 2008, 283, 28584–28594.
[13]  Yamashita, T.; Mao, S.Y.; Metzger, H. Aggregation of the high-affinity IgE receptor and enhanced activity of p53/56lyn protein-tyrosine kinase. Proc. Natl. Acad. Sci. USA 1994, 91, 11251–11255, doi:10.1073/pnas.91.23.11251.
[14]  Parravicini, V.; Gadina, M.; Kovarova, M.; Odom, S.; Gonzalez-Espinosa, C.; Furumoto, Y.; Saitoh, S.; Samelson, L.E.; O'Shea, J.J.; Rivera, J. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat. Immunol. 2002, 3, 741–748.
[15]  Chung, C.Y.; Potikyan, G.; Firtel, R.A. Control of cell polarity and chemotaxis by Akt/PKB and PI3 kinase through the regulation of PAKa. Mol. Cell 2001, 7, 937–947, doi:10.1016/S1097-2765(01)00247-7.
[16]  Datta, S.R.; Brunet, A.; Greenberg, M.E. Cellular survival: A play in three Akts. Genes Dev. 1999, 13, 2905–2927, doi:10.1101/gad.13.22.2905.
[17]  Lawlor, M.A.; Alessi, D.R. PKB/Akt: A key mediator of cell proliferation, survival and insulin responses? J. Cell Sci. 2001, 114, 2903–2910.
[18]  Manning, B.D.; Cantley, L.C. AKT/PKB signaling: Navigating downstream. Cell 2007, 129, 1261–1274, doi:10.1016/j.cell.2007.06.009.
[19]  Kitaura, J.; Asai, K.; Maeda-Yamamoto, M.; Kawakami, Y.; Kikkawa, U.; Kawakami, T. Akt-dependent cytokine production in mast cells. J. Exp. Med. 2000, 192, 729–740, doi:10.1084/jem.192.5.729.
[20]  Alvarez-Errico, D.; Yamashita, Y.; Suzuki, R.; Odom, S.; Furumoto, Y.; Yamashita, T.; Rivera, J. Functional analysis of Lyn kinase A and B isoforms reveals redundant and distinct roles in FcεRI-dependent mast cell activation. J. Immunol. 2010, 184, 5000–5008, doi:10.4049/jimmunol.0904064.
[21]  Tinti, M.; Nardozza, A.P.; Ferrari, E.; Sacco, F.; Corallino, S.; Castagnoli, L.; Cesareni, G. The 4G10, PY20 and p-TYR-100 antibody specificity: Profiling by peptide microarrays. New Biotechnol. 2012, 29, 571–577.
[22]  Tharp, M.D.; Seelig, L.L., Jr.; Tigelaar, R.E.; Bergstresser, P.R. Conjugated avidin binds to mast cell granules. J. Histochem. Cytochem. 1985, 33, 27–32, doi:10.1177/33.1.2578142.
[23]  Heib, V.; Becker, M.; Warger, T.; Rechtsteiner, G.; Tertilt, C.; Klein, M.; Bopp, T.; Taube, C.; Schild, H.; Schmitt, E.; et al. Mast cells are crucial for early inflammation, migration of langerhans cells, and CTL responses following topical application of TLR7 ligand in mice. Blood 2007, 110, 946–953.
[24]  Charles, N.; Hardwick, D.; Daugas, E.; Illei, G.G.; Rivera, J. Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat. Med. 2010, 16, 701–707, doi:10.1038/nm.2159.
[25]  Pribluda, V.S.; Pribluda, C.; Metzger, H. Transphosphorylation as the mechanism by which the high-affinity receptor for IgE is phosphorylated upon aggregation. Proc. Natl. Acad. Sci. USA 1994, 91, 11246–11250, doi:10.1073/pnas.91.23.11246.
[26]  Eiseman, E.; Bolen, J.B. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature 1992, 355, 78–80, doi:10.1038/355078a0.
[27]  Kitaura, J.; Song, J.; Tsai, M.; Asai, K.; Maeda-Yamamoto, M.; Mocsai, A.; Kawakami, Y.; Liu, F.T.; Lowell, C.A.; Barisas, B.G.; et al. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcεRI. Proc. Natl. Acad. Sci. USA 2003, 100, 12911–12916, doi:10.1073/pnas.1735525100.
[28]  Mao, S.Y.; Metzger, H. Characterization of protein-tyrosine phosphatases that dephosphorylate the high affinity IgE receptor. J. Biol. Chem. 1997, 272, 14067–14073, doi:10.1074/jbc.272.22.14067.
[29]  Hernandez-Hansen, V.; Smith, A.J.; Surviladze, Z.; Chigaev, A.; Mazel, T.; Kalesnikoff, J.; Lowell, C.A.; Krystal, G.; Sklar, L.A.; Wilson, B.S.; et al. Dysregulated FcεRI signaling and altered Fyn and SHIP activities in Lyn-deficient mast cells. J. Immunol. 2004, 173, 100–112.
[30]  Liu, F.T.; Bohn, J.W.; Ferry, E.L.; Yamamoto, H.; Molinaro, C.A.; Sherman, L.A.; Klinman, N.R.; Katz, D.H. Monoclonal dinitrophenyl-specific murine IgE antibody: Preparation, isolation, and characterization. J. Immunol. 1980, 124, 2728–2737.
[31]  Rivera, J.; Kinet, J.P.; Kim, J.; Pucillo, C.; Metzger, H. Studies with a monoclonal antibody to the β subunit of the receptor with high affinity for immunoglobulin E. Mol. Immunol. 1988, 25, 647–661, doi:10.1016/0161-5890(88)90100-9.
[32]  Suzuki, R.; Liu, X.; Olivera, A.; Aguiniga, L.; Yamashita, Y.; Blank, U.; Ambudkar, I.; Rivera, J. Loss of TRPC1-mediated Ca2+ influx contributes to impaired degranulation in Fyn-deficient mouse bone marrow-derived mast cells. J. Leukoc. Biol. 2010, 88, 863–875.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413